WHO Unveils Comprehensive Tobacco Cessation Guidelines to Aid 750 Million Smokers

In a landmark move, the World Health Organization (WHO) has introduced its first-ever comprehensive guidelines aimed at aiding tobacco users in quitting their addiction

The guidelines encompass a range of interventions, including behavioral support from healthcare providers, digital cessation tools, and pharmacological treatments. This initiative targets the over 750 million tobacco users worldwide who wish to quit various forms of tobacco, including cigarettes, waterpipes, smokeless tobacco, cigars, roll-your-own tobacco, and heated tobacco products (HTPs).

A Crucial Milestone in Global Health

“This guideline marks a crucial milestone in our global battle against these dangerous products,” stated Dr. Tedros Adhanom Ghebreyesus, WHO Director-General. “It empowers countries with the essential tools to effectively support individuals in quitting tobacco and alleviate the global burden of tobacco-related diseases.”

Despite 60% of the world’s 1.25 billion tobacco users expressing a desire to quit, 70% lack access to effective cessation services due to various challenges, particularly in health systems with limited resources.

Recognizing the Struggle

“The immense struggle that people face when trying to quit smoking cannot be overstated. We need to deeply appreciate the strength it takes and the suffering endured by individuals and their loved ones to overcome this addiction,” said Dr. Rüdiger Krech, Director of Health Promotion at WHO. ”These guidelines are designed to help communities and governments provide the best possible support and assistance for those on this challenging journey.”

Effective Therapies for Quitting Tobacco

The WHO highlights that combining pharmacotherapy with behavioral interventions significantly increases the success rates of quitting tobacco. To improve accessibility, particularly in low- and middle-income countries, the organization encourages countries to provide these treatments at no or reduced cost.

The recommended treatments for tobacco cessation include varenicline, Nicotine Replacement Therapy (NRT), bupropion, and cytisine. In a bid to improve global access to these medications, WHO initiated a prequalification procedure for medicinal products against disorders caused by tobacco use in 2023. In April 2024, Kenvue’s nicotine gum and patch became the first WHO-prequalified NRT products.

Behavioral and Digital Interventions

The guidelines also advocate for behavioral interventions, such as brief health worker counselling (lasting between 30 seconds and 3 minutes) routinely offered in healthcare settings. More intensive behavioral support, including individual, group, or phone counselling, is recommended for those interested. Additionally, digital interventions, such as text messaging, smartphone apps, and internet programs, can be valuable adjuncts or self-management tools.

WHO urges healthcare providers, policymakers, and stakeholders to adopt and implement these guidelines to promote tobacco cessation and enhance the health of millions worldwide. The comprehensive set of interventions outlined in the guidelines offers a robust framework to support tobacco users on their journey to quit, thereby reducing the global burden of tobacco-related diseases and improving public health outcomes.

By providing effective support and interventions, WHO aims to empower individuals to overcome tobacco addiction and pave the way for a healthier future for all.